Smith & Nephew plc - ADR
SNN
Get informed when a big investor buys or sells
+ Follow
Current Fair Value
36.3% downsideOvervalued by 36.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.97 Billion |
|---|---|
| Enterprise Value | $15.74 Billion |
| Dividend Yield | $0.78 (2.56%) |
| Earnings per Share | $1.46 |
| Beta | 0.67 |
| Outstanding Shares | 433,417,000 |
Return
| Return on Equity | 19.63% |
|---|---|
| Return on Assets | 9.93% |
| Return on Invested Capital | 19.39% |
Valuation & Multiples
| P/E Ratio | 20.63 |
|---|---|
| PEG | 30.76 |
| Price to Sales | 1.13 |
| Price to Book Ratio | 2.55 |
| Enterprise Value to Revenue | 1.31 |
| Enterprise Value to EBIT | 9.16 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.63 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.34%▼ 0.08% |
|---|---|
| Total Invested | $1.01B▼ 4.94% |
| Investors Holding | 277▲ 14.00% |
ESG Score
No data
About Smith & Nephew plc
CEO: Roland Diggelmann Relevant Senate Committees
Controls tax policy, trade agreements, and entitlement spending (e.g., Medicare and Medicaid reimbursement rates), all of which directly and significantly impact SNN's profitability and market access within the US.
Directly allocates federal spending to government agencies and healthcare programs, impacting sales, research funding, and procurement for medical device companies like SNN.
Direct oversight of the FDA, which regulates the approval and marketing of medical devices critical to SNN's business. Also influences labor laws affecting manufacturing costs.
Central to intellectual property protection (patents are crucial for medical devices) and antitrust enforcement, directly impacting SNN's competitive landscape and potential M&A strategies.
Funding decisions and oversight of the Department of Veterans Affairs directly impact government healthcare contractors and medical device manufacturers like SNN, as VA hospitals are major purchasers.